MetLife Investment Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,108,911
| Closed | -$22M | – | 2742 |
|
|
2025
Q1 | $22M | Buy |
1,108,911
+972,699
| +714% | +$19.3M | 0.12% | 132 |
|
|
2024
Q4 | $2.34M | Buy |
136,212
+6,060
| +5% | +$104K | 0.01% | 961 |
|
|
2024
Q3 | $2.6M | Hold |
130,152
| – | – | 0.01% | 888 |
|
|
2024
Q2 | $1.46M | Buy |
130,152
+21,693
| +20% | +$243K | 0.01% | 1141 |
|
|
2024
Q1 | $716K | Sell |
108,459
-2,007
| -2% | -$13.2K | ﹤0.01% | 1487 |
|
|
2023
Q4 | $499K | Hold |
110,466
| – | – | ﹤0.01% | 1683 |
|
|
2023
Q3 | $395K | Hold |
110,466
| – | – | ﹤0.01% | 1775 |
|
|
2023
Q2 | $408K | Hold |
110,466
| – | – | ﹤0.01% | 1840 |
|
|
2023
Q1 | $366K | Buy |
110,466
+23,110
| +26% | +$76.5K | ﹤0.01% | 1847 |
|
|
2022
Q4 | $339K | Sell |
87,356
-10,902
| -11% | -$42.3K | ﹤0.01% | 1886 |
|
|
2022
Q3 | $239K | Hold |
98,258
| – | – | ﹤0.01% | 2168 |
|
|
2022
Q2 | $195K | Buy |
+98,258
| New | +$195K | ﹤0.01% | 2341 |
|
|
2020
Q2 | – | Sell |
-36,875
| Closed | -$106K | – | 2298 |
|
|
2020
Q1 | $106K | Buy |
+36,875
| New | +$106K | ﹤0.01% | 2040 |
|
|
2019
Q4 | – | Sell |
-26,341
| Closed | -$117K | – | 2301 |
|
|
2019
Q3 | $117K | Buy |
+26,341
| New | +$117K | ﹤0.01% | 2244 |
|